Bioptik Technology Incorporation (TPEX:4161)
Taiwan
· Delayed Price · Currency is TWD 24.45
-1.00 (-3.93%)
Mar 9, 2026, 1:30 PM CST
TPEX:4161 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 837.19 | 865.34 | 828.5 | 767.75 | 737.89 | Upgrade
|
| Revenue Growth (YoY) | -3.25% | 4.45% | 7.91% | 4.05% | 51.95% | Upgrade
|
| Cost of Revenue | 593.68 | 597.43 | 588.96 | 590.29 | 574.35 | Upgrade
|
| Gross Profit | 243.51 | 267.91 | 239.54 | 177.46 | 163.55 | Upgrade
|
| Selling, General & Admin | 101.77 | 102.56 | 77.83 | 79.9 | 79.17 | Upgrade
|
| Research & Development | 75.2 | 75.35 | 71.47 | 58.3 | 48.94 | Upgrade
|
| Other Operating Expenses | -0.2 | - | - | - | - | Upgrade
|
| Operating Expenses | 176.78 | 178.07 | 149.59 | 137.99 | 127.82 | Upgrade
|
| Operating Income | 66.73 | 89.84 | 89.95 | 39.48 | 35.73 | Upgrade
|
| Interest Expense | -7.61 | -9.13 | -11 | -9.19 | -7.82 | Upgrade
|
| Interest & Investment Income | 3.87 | 8.99 | 10.7 | 4.01 | 1.36 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 13.32 | 4.95 | 29.94 | -9.45 | Upgrade
|
| Other Non Operating Income (Expenses) | 22.32 | 3.57 | 3.14 | 4.62 | 5.52 | Upgrade
|
| EBT Excluding Unusual Items | 85.32 | 106.58 | 97.75 | 68.86 | 25.34 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 4.63 | 8.69 | -6.14 | -5.72 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -0.9 | 0.02 | 0.06 | 0 | Upgrade
|
| Other Unusual Items | - | - | 0.02 | 0.03 | - | Upgrade
|
| Pretax Income | 85.32 | 110.32 | 106.47 | 62.81 | 19.62 | Upgrade
|
| Income Tax Expense | 15.48 | 17.98 | 21.89 | 15.78 | -0.94 | Upgrade
|
| Earnings From Continuing Operations | 69.84 | 92.34 | 84.58 | 47.03 | 20.56 | Upgrade
|
| Minority Interest in Earnings | 1.35 | 1.23 | 1.13 | 1.47 | 2.04 | Upgrade
|
| Net Income | 71.19 | 93.57 | 85.71 | 48.5 | 22.59 | Upgrade
|
| Net Income to Common | 71.19 | 93.57 | 85.71 | 48.5 | 22.59 | Upgrade
|
| Net Income Growth | -23.92% | 9.17% | 76.73% | 114.67% | - | Upgrade
|
| Shares Outstanding (Basic) | 58 | 58 | 58 | 57 | 57 | Upgrade
|
| Shares Outstanding (Diluted) | 59 | 59 | 58 | 58 | 57 | Upgrade
|
| Shares Change (YoY) | 0.27% | 1.18% | 0.77% | 0.33% | 0.15% | Upgrade
|
| EPS (Basic) | 1.23 | 1.62 | 1.49 | 0.85 | 0.39 | Upgrade
|
| EPS (Diluted) | 1.21 | 1.59 | 1.48 | 0.84 | 0.39 | Upgrade
|
| EPS Growth | -24.04% | 7.79% | 75.34% | 113.67% | - | Upgrade
|
| Free Cash Flow | 40.82 | 143.9 | 175.53 | 38.13 | -60.29 | Upgrade
|
| Free Cash Flow Per Share | 0.69 | 2.45 | 3.03 | 0.66 | -1.05 | Upgrade
|
| Dividend Per Share | - | 0.266 | 0.619 | - | 0.253 | Upgrade
|
| Dividend Growth | - | -57.12% | - | - | - | Upgrade
|
| Gross Margin | 29.09% | 30.96% | 28.91% | 23.11% | 22.16% | Upgrade
|
| Operating Margin | 7.97% | 10.38% | 10.86% | 5.14% | 4.84% | Upgrade
|
| Profit Margin | 8.50% | 10.81% | 10.35% | 6.32% | 3.06% | Upgrade
|
| Free Cash Flow Margin | 4.88% | 16.63% | 21.19% | 4.97% | -8.17% | Upgrade
|
| EBITDA | 99.5 | 120.11 | 119.73 | 67.73 | 67.29 | Upgrade
|
| EBITDA Margin | 11.88% | 13.88% | 14.45% | 8.82% | 9.12% | Upgrade
|
| D&A For EBITDA | 32.77 | 30.27 | 29.78 | 28.25 | 31.57 | Upgrade
|
| EBIT | 66.73 | 89.84 | 89.95 | 39.48 | 35.73 | Upgrade
|
| EBIT Margin | 7.97% | 10.38% | 10.86% | 5.14% | 4.84% | Upgrade
|
| Effective Tax Rate | 18.14% | 16.30% | 20.56% | 25.12% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.